COVID-19 vaccination schedule for most people

People ages 6 months through 4 years should receive:
Either Moderna primary dose 1 followed in 4 to 8 weeks by primary dose 2 followed in at least 2 months by a bivalent Moderna booster that targets the Omicron variant.
Or Pfizer-BioNTech primary dose 1 followed in 3 to 8 weeks by primary dose 2 followed in at least 8 weeks by primary dose 3 of the bivalent Pfizer vaccine that targets the Omicron variant.

People age 5 years should receive:
Either Moderna primary dose 1 followed in 4 to 8 weeks by primary dose 2 followed in at least 2 months by a booster of bivalent mRNA vaccine that targets the Omicron variant.
Or Pfizer-BioNTech primary dose 1 followed in 3 to 8 weeks by primary dose 2 followed in at least 8 weeks by primary dose 3 of the bivalent Pfizer vaccine that targets the Omicron variant.
 

People ages 6 through 11 years should receive:
Either Moderna primary dose 1 followed in 4 to 8 weeks by primary dose 2 followed in at least 2 months by a booster of a bivalent mRNA vaccine that targets the Omicron variant.
Or Pfizer-BioNTech primary dose 1 followed in 3 to 8 weeks by primary dose 2 followed in at least 2 months by a booster of a bivalent mRNA vaccine that targets the Omicron variant.

People ages 12 years and older should receive the Moderna, Novavax, or Pfizer-BioNTech vaccine.
Either Moderna primary dose 1 followed in 4 to 8 weeks by primary dose 2 followed in at least 2 months by a booster of a bivalent mRNA vaccine that targets the Omicron variant. 
Or Novavax or Pfizer-BioNTech primary dose 1 followed in 3 to 8 weeks by primary dose 2 followed in at least 2 months by a booster of a bivalent mRNA vaccine that targets the Omicron variant.

A monovalent Novavax booster dose may be used in limited situations in people age 18 years and older who completed a primary series using any COVID-19 vaccine, have not received any previous booster dose(s), and are unable or unwilling to receive an mRNA vaccine. The monovalent Novavax booster dose is administered at least 6 months after completion of a primary series.

People ages 18 years and older who previously received Janssen (J&J) vaccine for their primary series dose should follow it in at least 2 months with a booster of a bivalent mRNA vaccine that targets the Omicron variant. Janssen (J&J) vaccine should only be used in certain limited situations.